Trypanosoma cruzi: Effect of the absence of 5-lipoxygenase (5-LO)-derived leukotrienes on levels of cytokines, nitric oxide and iNOS expression in cardiac tissue in the acute phase of infection in mice

Experimental Parasitology

Volumn 127, Issue 1, 2011, Pages 58-65

  Panis, Carolina ^a   Mazzuco, Tânia Longo ^b   Costa, Cauê Zortéa Fernandes ^a   Victorino, Vanessa Jacob ^a   Tatakihara, Vera Lúcia Hideko ^a   Yamauchi, Lucy Megumi ^a   Yamada Ogatta, Sueli Fumie ^a   Cecchini, Rubens ^a   Rizzo, Luiz Vicente ^c   Pinge Filho, Phileno ^a  

^a STATE UNIVERSITY OF LONDRINA   (Brazil)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^c HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

Author keywords

Cardiac parasitism; IL 6; Leukotrienes; Nitric oxide; Resistance; Trypanosoma cruzi

Indexed keywords

ARACHIDONATE 15 LIPOXYGENASE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; LEUKOTRIENE; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHAGAS DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; IN VIVO STUDY; MACROPHAGE; MALE; MOUSE; NONHUMAN; PARASITE LOAD; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRYPANOSOMA CRUZI;

ACUTE DISEASE; ANIMALS; ARACHIDONATE 5-LIPOXYGENASE; CHAGAS CARDIOMYOPATHY; CYTOKINES; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEART; IMMUNOHISTOCHEMISTRY; LEUKOTRIENES; MALE; MICE; MICE, KNOCKOUT; MYOCARDIUM; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II;

MUS; TRYPANOSOMA CRUZI;

EID: 78650575218     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2010.06.030     Document Type: Article

References (53)

1. Abrahamsohn I.A., Coffman R.L. Cytokine and nitric oxide regulation of the immunosuppression in Trypanosoma cruzi infection. Journal of Immunology 1995, 155:3955-3963.
2. Andrade Z.A. Pathogenesis of Chagas' disease. Research Immunology 1991, 142:126-129.
3. Anstead G.M., Chandrasekar B., Zhao W., Yang J., Perez L., Melby P.C. Malnutrition alters the innate immune response and increases early visceralization following Leishmania donovani infection. Infection and Immunity 2001, 69:4709-4718.
4. Anstead G.M., Zhang Q., Melby P.C. Malnutrition promotes prostaglandin over leukotriene production and dysregulates eicosanoid-cytokine crosstalk in activated resident macrophages. Prostaglandins, Leukotrienes and Essential Fatty Acids 2009, 81:41-51.
5. Arantes R.M., Marche H.H., Bahia M.T., Cunha F.Q., Rossi M.A., Silva J.S. Interferon-gamma-induced nitric oxide causes intrinsic intestinal denervation in Trypanosoma cruzi-infected mice. American Journal of Pathology 2004, 164:1361-1368.
6. Borges M.M., Kloetzel J.K., Andrade H.F., Tadokoro C.E., Pinge-Filho P., Abrahamsohn I.A. Prostaglandin and nitric oxide regulate TNF-alpha production during Trypanosoma cruzi infection. Immunology Letters 1998, 63:1-8.
7. Borges C.L., Cecchini R., Tatakihara V.L.H., Malvezi A.D., Yamada-Ogatta S.F., Rizzo L.V., Pinge-Filho P. 5-Lipoxygenase plays a role in the control of parasite burden and contributes to oxidative damage of erythrocytes in murine Chagas' disease. Immunology Letters 2009, 123:38-45.
8. Brener Z. Therapeutic activity and criterion of cure on mice experimentally infected with Trypanosoma cruzi. Revista do Instituto de Medicina Tropical de São Paulo 1962, 4:389-396.
9. Chandrasekar B., Melby P.C., Troyer D.A., Freeman G.L. Induction of proinflammatory cytokine expression in experimental acute Chagasic cardiomyopathy. Biochemical and Biophysical Research Communications 1996, 223:365-371.
10. Chandrasekar B., Melby P.C., Troyer D.A., Freeman G.L. Differential regulation of nitric oxide synthase isoforms in experimental acute Chagasic cardiomyopathy. Clinical Experimental Immunology 2000, 121:112-119.
11. Chen X.S., Sheller J.R., Johnson E.N., Funk C.D. Role of leukotrienes revealed by targeted disruption of the 5-lipoxygenase gene. Nature 1994, 372:179-182.
12. Cummings K.L., Tarleton R.L. Inducible nitric oxide synthase is not essential for control of Trypanosoma cruzi infection in mice. Infection and Immunity 2004, 72:4081-4089.
13. Cunha-Neto E., Nogueira L.G., Teixeira P.C., Ramasawmy R., Drigo S.A., Goldberg A.C., Fonseca S.G., Bilate A.M., Kalil J. Immunological and non-immunological effects of cytokines and chemokines in the pathogenesis of chronic Chagas disease cardiomyopathy. Memórias do Instituto Oswaldo Cruz 2009, 104:252-258.
14. DiMeo D., Tian J., Zhang J., Narushima S., Berg D.J. Increased interleukin-10 production and Th2 skewing in the absence of 5-lipoxygenase. Immunology 2008, 123:250-262.
15. Gao W., Pereira M.A. Interleukin-6 is required for parasite specific response and host resistance to Trypanosoma cruzi. International Journal for Parasitology 2002, 32:167-170.
16. Gazzinelli R.T., Oswald I.P., Hieny S., James S.L., Sher A. The microbicidal activity of interferon-gamma-treated macrophages against Trypanosoma cruzi involves an l-arginine-dependent, nitrogen oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-beta. European Journal of Immunology 1992, 22:2501-2506.
17. Hoft D.F., Schnapp A.R., Eickhoff C.S., Roodman S.T. Involvement of CD4 Th1 cells in systemic immunity protective against primary and secondary challenges with Trypanosoma cruzi. Infection and Immunity 2000, 68:197-204.
18. Huang H., Chan J., Wittner M., Jelicks L.A., Morris S.A., Factor S.M., Weiss L.M. Trypanosoma cruzi infection induces myocardial nitric oxide synthase. Cardiovascular Pathology 1997, 6:161-166.
19. Jozefowski S., Biedron R., Bobek M., Marcinkiewicz J. Leukotrienes modulate cytokine release from dendritic cells. Immunology 2005, 116:418-428.
20. Kumar S., Tarleton R.L. Antigen-specific Th1 but not Th2 cells provide protection from lethal Trypanosoma cruzi infection in mice. Journal of Immunology 2001, 166:4596-4603.
21. Machado F.S., Martins G.A., Aliberti J.C., Mestriner F.L., Cunha F.Q., Silva J.S. Trypanosoma cruzi-infected cardiomyocytes produce chemokines and cytokines that trigger potent nitric oxide-dependent trypanocidal activity. Circulation 2000, 102:3003-3008.
22. Machado E.R., Ueta M., Lourenço E.V., Aníbal F.F., Sorgi C.A., Soares E.G., Roque-Barreira M.C., Medeiros A.I., Faccioli L.H. Leukotrienes play a role in the control of parasite burden in murine strongyloidiasis. Journal of Immunology 2005, 175:3892-3899.
23. Malvezi A.D., Cecchini R., Souza F., Tadokoro C.E., Rizzo L.V., Pinge-Filho P. Involvement of nitric oxide (NO) and TNF-α in the oxidative stress associated with anemia in experimental Trypanosoma cruzi infection. FEMS Immunology and Medical Microbiology 2004, 41:69-77.
24. Medeiros A.I., Sá-Nunes A., Soares E.G., Peres C.M., Silva C.L., Faccioli L.H. Blockade of endogenous leukotrienes exacerbates pulmonary histoplasmosis. Infection and Immunity 2004, 72:1637-1644.
25. Metz G., Carlier Y., Vray B. Trypanosoma cruzi upregulates nitric oxide release by IFN-gamma-preactivated macrophages, limiting cell infection independently of the respiratory burst. Parasite Immunology 1993, 15:693-699.
26. Michailowsky V., Silva N.M., Rocha C.D., Vieira L.Q., Lannes-Vieira J., Gazzinelli R.T. Pivotal role of interleukin-12 and interferon-gamma axis in controlling tissue parasitism and inflammation in the heart and central nervous system during Trypanosoma cruzi infection. American Journal of Pathology 2001, 159:1723-1733.
27. Michelin M.A., Silva J.S., Cunha F.Q. Inducible cyclooxygenase released prostaglandin mediates immunosuppression in acute phase of experimental Trypanosoma cruzi infection. Experimental Parasitology 2005, 111:71-79.
28. Miller K. Immunohistochemical techniques. Theory and Practice of Histological Techniques 1996, 435-470. Churchill Livingstone, Hong Kong. J.D. Bancroft, A. Stevens (Eds.).
29. Munoz-Fernandez M.A., Fernandez M.A., Fresno M. Synergism between tumor necrosis factor-alpha and interferon-gamma on macrophage activation for the killing of intracellular Trypanosoma cruzi through a nitric oxide-dependent mechanism. European Journal of Immunology 1992, 22:301-307.
30. Navarro-Gonzálvez J.A., García-Benayas C., Arenas J. Semiautomated measurement of nitrate in biological fluids. Clinical Chemistry 1998, 44:670-681.
31. Pavanelli, W.R., Gutierrez, F.R., Mariano, F.S., Prado, C.M., Ferreira, B.R., Teixeira, M.M., Canetti, C., Rossi, M.A., Cunha, F.Q., Silva, J.S., in press. 5-Lipoxygenase is a key determinant of acute myocardial inflammation and mortality during Trypanosoma cruzi infection. Microbes and Infection, doi:10.1016/j.micinf.2010.03.016.
32. Peters-Golden M., Henderson W.R. Leukotrienes. New England Journal of Medicine 2007, 357:1841-1854.
33. Petray P., Rottenberg M.E., Grinstein S., Orn A. Release of nitric oxide during the experimental infection with Trypanosoma cruzi. Parasite Immunology 1994, 16:193-199.
34. Pinge-Filho P., Tadokoro C.E., Abrahamsohn I.A. Prostaglandins-mediated suppression of lymphoproliferation and cytokine synthesis during the early phase of Trypanosoma cruzi infection. Cellular Immunology 1999, 193:90-98.
35. Pinge-Filho P., Peron J.P., de Moura T.R., Menolli R.A., Graça V.K., Estevão D., Tadokoro C.E., Jankevicius J.V., Rizzo L.V. Phytomonas serpens, a tomato parasite, shares antigens with Trypanosoma cruzi that are recognized by human sera and induce protective immunity in mice. Immunology Letters 2005, 96:283-290.
36. Poubelle P.E., Stankova J., Grassi J., Rola-Pleszczynski M. Leukotriene B4 up-regulates IL-6 rather than IL-1 synthesis in human monocytes. Agents Actions 1991, 34:42-45.
37. Rassi A.J.R., Rassi A., Marin-Neto J.A. Chagas heart disease: pathophysiologic mechanisms, prognostic factors and risk stratification. Memórias do Instituto Oswaldo Cruz 2009, 104:152-158.
38. Reyes J.L., Terrazas L.I., Espinoza B., Cruz-Robles D., Soto V., Rivera-Montoya I., Gómez-García L., Snider H., Satoskar H.R., Rodríguez-Sosa M. Macrophage migration inhibitory factor contributes to host defense against acute Trypanosoma cruzi. Infection and Immunity 2006, 74:3170-3179.
39. Rocha M.O., Ribeiro A.L., Teixeira M.M. An update on the management of Chagas cardiomyopathy. Expert Reviews in Anti Infectious Therapy 2007, 5:727-743.
40. Roggero E., Pérez A.R., Tamae-Kakazu M., Piazzon I., Nepomnaschy I., Besedovsky H.O., Bottasso O.A., del Rey A. Endogenous glucocorticoids cause thymus atrophy but are protective during acute Trypanosoma cruzi infection. Journal of Endocrinology 2006, 190:495-503.
41. Rola-Pleszczynski M., Stanková J. Leukotriene B4 enhances interleukin-6 (IL-6) production and IL-6 messenger RNA accumulation in human monocytes in vitro: transcriptional and posttranscriptional mechanisms. Blood 1992, 80:1004-1011.
42. Saavedra E., Herrera M., Gao W., Uemura H., Pereira M.A. The Trypanosoma cruzi trans-sialidase, through its COOH-terminal tandem repeat, upregulates interleukin 6 secretion in normal human intestinal microvascular endothelial cells and peripheral blood mononuclear cells. Journal of Experimental Medicine 1999, 190:1825-1836.
43. Saeftel M., Fleischer B., Hoerauf A. Stage-dependent role of nitric oxide in control of Trypanosoma cruzi infection. Infection and Immunity 2001, 69:2252-2259.
44. Serezani C.H.C., Aronoff D.M., Jancar S., Mancuso P., Peters-Golden M. Leukotrienes enhance the bactericidal activity of alveolar macrophages against Klebsiella pneumoniae through the activation of NADPH oxidase. Blood 2005, 106:1067-1073.
45. Serezani C.H., Perrela J.H., Russo M., Peters-Golden M., Jancar S. Leukotrienes are essential for the control of Leshmania amazonensis infection and contribute to strain variation in susceptibility. Journal of Immunology 2006, 177:3201-3208.
46. Shimizu T. Lipid mediators in health and disease: enzymes and receptors as therapeutic targets for the regulation of immunity and inflammation. Annual Review of Pharmacology and Toxicology 2009, 49:123-150.
47. Silva L.H.P., Nussensweig V. Sobre uma cepa de Trypanosoma cruzi altamente virulenta para o camundongo branco. Folha Clínica Biológica 1953, 20:191-207.
48. Silva S.S., Vespa G.N.R., Cardoso M.A.G., Aliberti J.C.S., Cunha F.Q. Tumor necrosis factor alfa mediates resistance to Trypanosoma cruzi infection in mice by inducing nitric oxide production in infected gamma interferon-activated macrophages. Infection and Immunity 1995, 12:4862-4867.
49. 4 induces nitric oxide synthesis in T. cruzi-infected murine macrophages and mediates resistance to infection. Infection and Immunity 2002, 12:4247-4253.
50. Tatakihara V.L.H., Cecchini R., Borges C.L., Malvezi A.D., Graça-de Souza V.K., Yamada-Ogatta S.F., Rizzo L.V., Pinge-Filho P. Effects of cyclooxygenase inhibitors on parasite burden, anemia and oxidative stress in murine Trypanosoma cruzi infection. FEMS Immunology and Medical Microbiology 2008, 52:47-58.
51. Truyens C., Angelo-Barrios A., Torrico F., Van Damme J., Heremans H., Carlier Y. Interleukin-6 (IL-6) production in mice infected with Trypanosoma cruzi: effect of its paradoxical increase by anti-IL-6 monoclonal antibody treatment on infection and acute-phase and humoral immune responses. Infection and Immunity 1994, 62:692-696.
52. Vespa G.N.R., Cunha F.Q., Silva J.S. Nitric oxide is involved in control of Trypanosoma cruzi-induced parasitemia and directly kills the parasite in vitro. Infection and Immunity 1994, 62:5177-5182.
53. 4 on macrophage association with an intracellular destruction of Trypanosoma cruzi. Journal of Immunology 1985, 134:1989-1993.